1. Home
  2. GNFT vs CIO Comparison

GNFT vs CIO Comparison

Compare GNFT & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • CIO
  • Stock Information
  • Founded
  • GNFT 1999
  • CIO 2013
  • Country
  • GNFT France
  • CIO Canada
  • Employees
  • GNFT N/A
  • CIO N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • CIO Real Estate Investment Trusts
  • Sector
  • GNFT Health Care
  • CIO Real Estate
  • Exchange
  • GNFT Nasdaq
  • CIO Nasdaq
  • Market Cap
  • GNFT 249.0M
  • CIO 230.9M
  • IPO Year
  • GNFT 2019
  • CIO 2014
  • Fundamental
  • Price
  • GNFT $6.10
  • CIO $5.46
  • Analyst Decision
  • GNFT Strong Buy
  • CIO
  • Analyst Count
  • GNFT 1
  • CIO 0
  • Target Price
  • GNFT $13.00
  • CIO N/A
  • AVG Volume (30 Days)
  • GNFT 27.9K
  • CIO 248.8K
  • Earning Date
  • GNFT 09-19-2024
  • CIO 10-31-2024
  • Dividend Yield
  • GNFT N/A
  • CIO 7.48%
  • EPS Growth
  • GNFT N/A
  • CIO N/A
  • EPS
  • GNFT 0.47
  • CIO N/A
  • Revenue
  • GNFT $86,225,222.00
  • CIO $175,370,000.00
  • Revenue This Year
  • GNFT $155.44
  • CIO N/A
  • Revenue Next Year
  • GNFT N/A
  • CIO $1.03
  • P/E Ratio
  • GNFT $12.48
  • CIO N/A
  • Revenue Growth
  • GNFT 175.45
  • CIO N/A
  • 52 Week Low
  • GNFT $2.97
  • CIO $3.46
  • 52 Week High
  • GNFT $6.13
  • CIO $6.71
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 70.40
  • CIO 36.59
  • Support Level
  • GNFT $5.41
  • CIO $5.35
  • Resistance Level
  • GNFT $5.84
  • CIO $6.00
  • Average True Range (ATR)
  • GNFT 0.31
  • CIO 0.20
  • MACD
  • GNFT 0.05
  • CIO -0.05
  • Stochastic Oscillator
  • GNFT 97.19
  • CIO 19.40

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About CIO City Office REIT Inc.

City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. The company owns office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.

Share on Social Networks: